95264 ⎘
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring-member bond
METHODS FOR TREATING CANCER
#2NOVEL CRYSTALLINE FORM OF ENAVOGLIFLOZIN, AND PREPARATION METHOD THEREFOR
#3CRYSTALLINE FORM OF SGLT INHIBITOR
#4METHOD FOR PREPARING SGLT INHIBITOR
#5Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#6INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN 4 AND PHOSPHOINOSITIDE 3-KINASE
#7NOVEL CO-CRYSTAL OF ENAVOGLIFLOZIN
#8PI3K INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
#9ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME
#10PYRAZOLE DERIVATIVES FOR THE INHIBITION OF PHAGOCYTOSIS
#11SWEETENER COMPOSITIONS
#12TRICYCLIC COMPOUNDS AND USES THEREOF
#13SUBSTITUTED COUMARIN DYES AND USES AS FLUORESCENT LABELS
#14POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF
#15SMALL MOLECULE INHIBITORS OF NAV1.8 SODIUM CHANNELS FOR PAIN RELIEF
#16ASCORBIC ACID DERIVATIVE OR SALT THEREOF, ADDITIVE FOR POLYMERIZATION INITIATION, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL
#17COMPOSITION FOR PREVENTING OR TREATING MULTIPLE MYELOMA COMPRISING NOVEL CHROMANON COMPOUND AS ACTIVE INGREDIENT
#18PARTHENOLIDE DERIVATIVES AND USE THEREOF
#19COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES
#20HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER
#21COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#22FUSED HETEROCYCLIC COMPOUNDS AS PI3KALPHA INHIBITORS
#23NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME
#24MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF
#25Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
#26POLYMERIZABLE COMPOSITIONS INCLUDING A POLYMERIZABLE COMPONENT AND A REDOX INITIATION SYSTEM CONTAINING A PHOTOLABILE REDUCING AGENT, AND A PHOTOLABILE REDUCING AGENT
#27BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS
#28HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT
#29Novel Dialkoxynaphtho[2,3-C]Furan-1(3H)-One Derivatives and Pharmaceutical Composition For Preventing or Treating Respiratory Disease or SARS-COV-2 Infection Disease, Comprising Same
#30Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#31Compounds and methods for inhibiting CYP26 enzymes
#32SUBSTITUTED COUMARIN DYES AND USES AS FLUORESCENT LABELS
#33NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#34PHARMACEUTICAL COMPOSITION FOR AMELIORATING MALIGNANT DISEASES
#35Composition for organic optoelectronic device, organic optoelectronic device, and display device
#36Composition for organic optoelectronic device, organic optoelectronic device, and display device
#37HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#38ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE
#39COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME
#40METHODS OF TREATING OCULAR FIBROTIC PATHOLOGIES
#41Substituted cyclic amides and their use as herbicides
#42Matrix metalloproteinase (MMP) inhibitors and methods of use thereof
#43RAR-ALPHA COMPOUNDS FOR INFLAMMATORY DISEASE AND MALE CONTRACEPTION
#44Composition for organic optoelectronic device, organic optoelectronic device, and display device
#45Compositions and methods of treating cardiac fibrosis with ifetroban
#46Compounds and organic electronic devices
#47POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF
#48Flavan-3-ol analogs and anti-inflammatory activity
#49ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE
#50HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME
#512-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof
#52TWO-PHOTON FLUORESCENT PROBE COMPOUND SELECTIVE FOR AMYLOID BETA PLAQUES AND METHOD FOR IMAGING AMYLOID BETA PLAQUES USING SAME
#53INTERMEDIATE USEFUL FOR SYNTHESIS OF SGLT INHIBITOR AND METHOD FOR PREPARING SGLT INHIBITOR USING SAME
#54Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease
#55PRODRUGS, ANALOGS OR DERIVATIVES OF KAEMPFEROL AS ANTIVIRAL AGENTS
#56Novel Quercetin Redox Derivative And Use Thereof As BET Inhibitor
#57Nitrogen-containing compound, and electronic element and electronic device using same
#58Compounds for the Treatment of Kinase-Dependent Disorders
#59FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF
#60Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease
#61Anticancer compounds
#62MANGIFERIN AND PREPARATION METHOD THEREOF
#63Organic compound, electronic element, and electronic device
#64Ligand-enabled β-C(sp)-H lactonization for β-C—H functionalizations
#65ANTIMALARIAL HEXAHYDROPYRIMIDINE ANALOGUES
#66Compounds and methods for treating fibrotic pathologies
#67CANNABINOID DERIVATIVES
#68ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME
#69Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#70BIARYL DERIVATIVE AS GPR120 AGONIST
#71Substituted cyclic amides and their use as herbicides
#72COMPOUNDS FOR THE INHIBITION OF UNREGULATED CELL GROWTH
#73LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING
#74Substituted coumarin dyes and uses as fluorescent labels
#75Synthetic Antibacterial Compounds and Uses Thereof
#76Method for producing epoxy compound
#774,6-PYRIMIDINYLENE DERIVATIVES AND USES THEREOF
#78Inhibition of respiratory complex III by ligands that interact with a regulatory switch
#79Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors
#80HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS
#81Compositions for the treatment of hypertension and/or fibrosis
#82Compounds and methods targeting GPER for treatment of diseases associated with calcium
#83Compound for treatment or prevention of liver diseases
#84Arylnaphthalene compounds as vacuolar-ATPase inhibitors and the use thereof
#85Dioxetane compounds and their use for the detection of microorganisms
#86Matrix metalloproteinase (MMP) inhibitors and methods of use thereof
#872-furyl- and 2-thienyl-substituted di- and tetrahydropyrans for use as aroma chemicals
#88Condensed cyclic compound and organic light-emitting device including the same
#89Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#90Compounds and organic electronic devices
#91Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
#92POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF
#93Compounds and methods for inhibiting CYP26 enzymes
#94Cannabinergic compounds and uses thereof
#95COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#962-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof
#97Andrographolide compound and method for treatment or prevention of fibrotic disease using the same
#98Autonomous device for measuring the characteristics of a fluid circulating in a conduit and system for controlling ventilation, air conditioning and/or heating using such a device
#99Arylnaphthalene compounds as vacuolar-ATPase inhibitors and the use thereof
#100Agonists of the mu opioid receptor
#101Condensed cyclic compound, organic light-emitting device including same, and electronic device including organic light-emitting device
#102Compounds and methods for inhibiting CYP26 enzymes
#103Substituted cyclic amides and their use as herbicides
#104Phenoxymethyl derivatives
#1054,6-PYRIMIDINYLENE DERIVATIVES AND USES THEREOF
#106Organic Electronic Device Comprising an Organic Semiconductor Layer
#107Compositions of certain manganese accumulating plants
#108ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE
#109Antibacterial compounds
#110Viral replication inhibitors
#111Non-aqueous electrolyte for lithium ion battery and lithium ion battery
#112Compositions and methods of treating cardiac fibrosis with ifetroban
#113Heteroaryl sulfonamides and CCR2/CCR9
#114Synthesis of 20-nor-salvinorin A
#115NOVEL POCHONIOLIDE COMPOUND AND USE THEREOF
#116Heterocyclic compound and organic light emitting diode containing same
#117HYDROXY FORMAMIDE DERIVATIVES AND THEIR USE
#118SMALL MOLECULE AGONISTS AND ANTAGONISTS OF NR2F6 ACTIVITY IN ANIMALS
#119Toll-like receptor 9 antagonists
#120Cyclization processes of hydroxyalkenoic acids and products thereof
#121Polycyclic compound and organic light emitting element comprising same
#122Compounds containing Si atoms for optically active devices
#123FUMAGILLOL TYPE COMPOUNDS AND METHODS OF MAKING AND USING SAME
#124Method for producing diphenylmethane derivative
#125Matrix metalloproteinase (MMP) inhibitors and methods of use thereof
#126MGluR7 agonist compounds for treating mGluR7-regulated diseases, disorders, or conditions
#1272-substituted amino-naphth (1,2-d) imidazol-5-one compounds or pharmaceutically acceptable salts thereof
#128Compositions and methods for the treatment of cancer
#129Anticancer compounds
#130Bis-diox(ol)ane compounds
#131Compositions and methods for treating tuberculosis
#132Substituted oxepines
#133Compositions and methods of treating cardiac fibrosis with ifetroban
#134USE OF PARTHENOLIDE DERIVATIVES AS ANTILEUKEMIC AND CYTOTOXIC AGENTS
#135Compositions for the treatment of hypertension and/or fibrosis
#136Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
#137Xanthone derivatives for the treatment of hepatitis B virus disease
#138Cannabinergic compounds and uses thereof
#139Method for producing diphenylmethane derivative
#140Heteroaryl sulfonamides and CCR2/CCR9
#141Polymer-conjugated METAP2 inhibitors, and therapeutic methods of use thereof
#142Compounds comprising triazine group, fluorene-group and aryl group
#143Substituted bicyclic heterocyclic compounds
#144NEW TOLL-LIKE RECEPTOR 9 ANTAGONISTS
#145Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
#146Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#147Materials for organic electroluminescent devices
#148Substituted 2-oxyimidazolylcarboxamides as pesticides
#149Process for the synthesis of intermediates of Nebivolol
#150Heterocyclic compounds as adenosine antagonists
#151Spiro-structured compound and organic electronic device comprising same
#152MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#153Fumigillol compounds and methods of making and using same
#154Organic light-emitting compound and organic light-emitting diode comprising same
#155Heterocyclic compound and organic light emitting diode containing same
#156Small molecule agonists and antagonists of NR2F6 activity in animals
#157Organic compound and organic electroluminescent device comprising same
#1584,6-pyrimidinylene derivatives and uses thereof
#159Compositions and methods of treating cardiac fibrosis with ifetroban
#160Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t))
#161Compositions and methods for treating tuberculosis
#162Trypanosomes inhibitors
#163Compound having EP2 agonist activity
#164Compositions and methods for detecting cancer cells in a tissue sample
#165TRIAZOLE COMPOUND
#166Phenoxymethyl derivatives
#167Methods of making fused ring compounds
#168Functionalised benzopyran compounds and use thereof
#169BIOSOURCED COMPOUND HAVING EPOXIDE FUNCTIONS, METHOD FOR THE SYNTHESIS OF SUCH A COMPOUND, AND USE THEREOF FOR PRODUCING EPOXY RESIN
#170Morphinan derivatives for the treatment of neuropathic pain
#171Compound for organic light-emitting device and organic light-emitting device including same
#172Pyrone derivatives for use as antiviral agents
#173BETA-NAPHTHOISOFLAVONES, COMPOSITIONS CONTAINING, AND USES OF, SAME
#1744,6-pyrimidinylene derivatives and uses thereof
#175Compounds and methods for IDO and TDO modulation, and indications therefor
#176Compounds and organic electronic devices
#177Butyrolactones as herbicides
#178Compounds having antioxidant activity against free radicals and anti-inflammatory activity, and corresponding pharmaceutical or cosmetic compositions for skin care
#179Lactate dehydrogenase inhibitor and antiepileptic drug containing the same
#180Condensed cyclic compound and organic light-emitting device including the same
#181Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
#182Antibacterial composition comprising an acetal or a long-chain alkyl hexitane ether
#183Biaryl derivative as GPR120 agonist
#184Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR γ (T))
#185Fumigillol compounds and methods of making and using same
#186N-,C-disubstituted azoles and compositions and methods for controlling nematode pests
#187Compound and organic light-emitting device including the same
#188Agonists of the mu opioid receptor
#189Heterocyclic compounds with benzo(c)coumarin-structures
#190Mangiferin-6-O-berberine salt and preparation method and use thereof
#191Flavonoid derivative compounds and method for preparing same by depolymerization of condensed tannins
#192Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
#193Compositions and methods of treating cardiac fibrosis with ifetroban
#194Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
#195Use of parthenolide derivatives as antileukemic and cytotoxic agents
#196Pharmaceutical compositions for the treatment of psoriasis
#197Heteroaryl sulfonamides and CCR2/CCR9
#198Bicyclic derivatives and pharmaceutical composition including the same
#199Methods of making fused ring compounds
#200Compound having selective EP2 agonist activity
#201Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
#202Functionalised benzopyran compounds and use thereof
#203Hydroxy formamide derivatives and their use
#2043-aryl-4H-chromene-4-ones as antineoplastic agents for the treatment of cancer
#205Method for producing silymarin
#206Substituted oxepines
#207N-,C-disubstituted azoles and compositions and methods for controlling nematode pests
#208Viral replication inhibitors
#209Pyrrolidinones as herbicides
#210Heteroaryl compounds as BTK inhibitors and uses thereof
#211Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
#212Process for producing dihydro-2H-pyran derivatives
#213PI3K/AKT/mTOR inhibitors and pharmaceutical uses thereof
#214Substituted N, N-dimethylaminoalkyl ethers of isoflavanone oximes as H-receptor antagonists
#215Liquid crystal compound having a 3,6-dihydro-2H-pyran ring, negative dielectric anisotropy, liquid crystal composition and liquid crystal display device
#216Substituted quinoxalines as FGFR kinase inhibitors
#217Compound and organic light-emitting device comprising the compound
#218Arginine methyltransferase inhibitors and uses thereof
#219Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
#220Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics
#221Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
#222Compound and organic light-emitting device including the same
#223Method for preparing long-chain alkyl cyclic acetals made from sugars
#224TERT-BUTYL SULPHOXIDE METHOD FOR PRODUCING FESTINAVIR
#225Novel Cannabinergic Compounds and Uses Thereof
#226CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
#227Liquid crystal compound having xanthene skeleton and exhibiting negative dielectric anisotropy, liquid crystal composition and liquid crystal display device
#228PREPARATION OF 2'-FLUORO-2'-ALKYL-SUBSTITUTED OR OTHER OPTIONALLY SUBSTITUTED RIBOFURANOSYL PYRIMIDINES AND PURINES AND THEIR DERIVATIVES
#229N-,C-disubstituted azoles and compositions and methods for controlling nematode pests
#2301,3-dioxane compound having fluorine atom in axial position, liquid crystal composition and liquid crystal display device
#231Organic compound, organic optoelectronic device and display device
#232Resin composition
#233Method for preparation of justicidin a derivatives of arylnaphthalene lignan structure
#234Methods of making fused ring compounds
#235C-terminal HSP90 inhibitors to treat pituitary adenomas
#236USE OF SUBSTITUTED 2,3-DIHYDRO-1-BENZOFURAN-4-CARBOXYLIC ACIDS OR SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS
#237Nucleoside kinase bypass compositions and methods
#238Aryl substituted heterocyclyl sulfones
#239TRANSKETALIZED COMPOSITIONS, SYNTHESIS, AND APPLICATIONS
#240SMALL MOLECULES FOR EXTENDING THE WELL BEING OF CELLS AND METHODS OF USE THEREOF
#241Chemiluminescent compositions, methods, assays and kits for oxidative enzymes
#242Method for manufacturing organic electronic devices
#243Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#244Use of parthenolide derivatives as antileukemic and cytotoxic agents
#245Dihydropyran compound, liquid crystal composition and liquid crystal display device
#246ASCORBIC ACID-RELATED COMPOUND AND PLANT ANTIVIRAL AGENT
#247Process for producing dihydro-2H-pyran derivatives
#248Quinolone compound and pharmaceutical composition
#249Griseofulvin derivatives
#250Griseofulvin derivatives
#251Bromodomain inhibitors
#252Catalysts for hydrodeoxygenation of oxygenated hydrocarbons
#253Compounds and organic electronic devices
#254FUSED QUINONIC COMPOUNDS
#255Use of certain manganese-accumulating plants for carrying out organic chemistry reactions
#256Diphenylmethane derivatives as SGLT2 inhibitors
#257Catalysts for hydrodeoxygenation of oxygenated hydrocarbons
#258Sulfilimine and sulphoxide methods for producing festinavir
#259Compounds for treating spinal muscular atrophy
#260Fumigillol type compounds and methods of making and using same
#261Small compounds targeting TACC3
#2625-FLUOROPYRIMIDINONE DERIVATIVES
#263Liquid crystal compound having tetrafluoropropenyl, liquid crystal composition, and liquid crystal display element
#264Polymerizable compound having oxygen-containing five-membered ring, liquid crystal composition and liquid crystal display device
#265Substituted quinoxalines as FGFR kinase inhibitors
#266Crystalline solids of a MetAP-2 inhibitor and methods of making and using same
#267Furo[3,2-b]- and thieno[3,2-b]pyridin derivatives
#268Plant growth regulating compounds
#269Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
#270Pyrrole derivatives
#271Solid forms of an antiviral compound
#272Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses thereof
#273PPAR MODULATORS
#274Arginine methyltransferase inhibitors and uses thereof
#275Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives
#276N-,C-disubstituted azoles and compositions and methods for controlling nematode pests
#277CHROMENE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
#2783,5-disubstituted-4,5-dihydro-1,2,4-oxadiazoles and compositions and methods for controlling nematode pests
#279Disubstituted 5-fluoro-pyrimidines
#280Compounds that Modulate Store Operated Calcium Channels
#281Process for the preparation of compounds useful as inhibitors of SGLT-2
#282Benzocycloheptane and benzoxepine derivatives
#283TRANSKETALIZED COMPOSITIONS, SYNTHESIS, AND APPLICATIONS
#284Inhibitors of viral replication, their process of preparation and their therapeutical uses
#285Quinolone compound and pharmaceutical composition
#286Compositions and methods for modulating the activity of Epstein-Barr nuclear antigen 1
#287Diphenylmethane derivatives as SGLT2 inhibitors
#2883,3′,4,4′-tetraalkyl cyclohexylbenzene and method for producing same
#289Catalysts for hydrodeoxygenation of oxygenated hydrocarbons
#290Inhibitors of viral replication, their process of preparation and their therapeutical uses
#291CHROMENE COMPOUND
#292Pharmaceutical compounds
#293Herbicidal pyrandione, thiopyrandione, and cyclohexanetrione derivatives
#294Fulvene and fulvalene analogs and their use in treating cancers
#295Iminipyridine derivatives and their uses as microbiocides
#296Polymer derivative of cytidine metabolic antagonist
#297Pyridinone and pyridazinone derivatives
#298Bicyclic compound and use thereof for medical purposes
#299Substituted heterocyclic compounds
#300Method for producing optically active fluorine-containing oxeten